NYSE: CXWCorecivic Inc Stock
$20.61-0.87 (-4.05%)
Updated Jun 13, 2025
CXW Price
$20.61
Fair Value Price
N/A
Market Cap
$2.25B
52 Week Low
$11.23
52 Week High
$24.99
P/E
27.12x
P/B
1.53x
P/S
1.13x
PEG
0.25x
Dividend Yield
N/A
Revenue
$1.95B
Earnings
$84.44M
Gross Margin
23.6%
Operating Margin
9.18%
Profit Margin
4.3%
Debt to Equity
1.04
Operating Cash Flow
$243M
Beta
0.74
Next Earnings
Aug 5, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CXW Overview
CoreCivic, Inc. owns and manages private prisons and detention centers and operates others on a concession basis. Among others, it has contracts with the Federal Bureau of Prisons, the US Marshals Service, and California Department of Corrections and Rehabilitation. Formerly Corrections Corporation of America, the company was founded in 1983 and is headquartered in Nashville, TN.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CXW's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Security & Protection Service
Industry Rating
A
CXW
Ranked#6 of 17
Ranked#6 of 17
Be the first to know about important CXW news, forecast changes, insider trades & much more!
CXW News
Overview
Due Diligence Score
–
Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CXW scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CXW ($20.61) is trading below its intrinsic value of $33.37, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CXW is good value based on its earnings relative to its share price (27.12x), compared to the US market average (31.36x)
P/E vs Market Valuation
CXW is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CXW due diligence checks available for Premium users.
Valuation
CXW price to earnings (PE)
For valuing profitable companies with steady earnings
Company
27.12x
Industry
30.15x
Market
31.36x
CXW is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CXW is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CXW price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.53x
Industry
2.94x
CXW is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CXW price to earnings growth (PEG)
For valuing profitable companies with growth potential
CXW is good value based... subscribe to Premium to read more.
PEG Value Valuation
CXW's financial health
Profit margin
Revenue
$488.6M
Net Income
$25.1M
Profit Margin
5.1%
CXW's Earnings (EBIT) of $179.04M... subscribe to Premium to read more.
Interest Coverage Financials
CXW's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.0B
Liabilities
$1.5B
Debt to equity
1.04
CXW's short-term assets ($413.45M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CXW's long-term liabilities ($1.26B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CXW's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CXW's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$44.5M
Investing
-$25.0M
Financing
-$53.7M
CXW's operating cash flow ($243.28M)... subscribe to Premium to read more.
Debt Coverage Financials
CXW vs Security & Protection Service Stocks
Corecivic Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.